Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.95 and traded as low as $5.50. Mannatech shares last traded at $5.70, with a volume of 7,293 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings upgraded Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, May 26th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.
Check Out Our Latest Report on Mannatech
Mannatech Price Performance
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its earnings results on Thursday, May 14th. The company reported $0.49 earnings per share (EPS) for the quarter. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 11.97%.The company had revenue of $24.92 million for the quarter.
Insider Transactions at Mannatech
In related news, Director Kevin Andrew Robbins bought 7,100 shares of the business’s stock in a transaction on Tuesday, May 19th. The shares were bought at an average price of $4.17 per share, for a total transaction of $29,607.00. Following the completion of the purchase, the director directly owned 33,333 shares of the company’s stock, valued at approximately $138,998.61. This trade represents a 27.07% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders bought a total of 14,903 shares of company stock valued at $62,155 in the last 90 days. 41.50% of the stock is owned by insiders.
About Mannatech
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Featured Articles
- Five stocks we like better than Mannatech
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
